They concluded that the overproduction of cyclins D1 and E and Cyclin Dependant Kinases Inhibitor (CDKI) p16 together with the deregulation of the Rb/E2F pathway may be involved in the development of human uveal melanoma. The gene discussed is CDKN2A; the disease is uveal melanoma.